241 related articles for article (PubMed ID: 24292792)
1. Human dendritic cells derived from embryonic stem cells stably modified with CD1d efficiently stimulate antitumor invariant natural killer T cell response.
Zeng J; Wang S
Stem Cells Transl Med; 2014 Jan; 3(1):69-80. PubMed ID: 24292792
[TBL] [Abstract][Full Text] [Related]
2. Enhancing immunostimulatory function of human embryonic stem cell-derived dendritic cells by CD1d overexpression.
Zeng J; Shahbazi M; Wu C; Toh HC; Wang S
J Immunol; 2012 May; 188(9):4297-304. PubMed ID: 22407918
[TBL] [Abstract][Full Text] [Related]
3. Olea europaea pollen lipids activate invariant natural killer T cells by upregulating CD1d expression on dendritic cells.
Abós-Gracia B; del Moral MG; López-Relaño J; Viana-Huete V; Castro L; Villalba M; Martínez-Naves E
J Allergy Clin Immunol; 2013 May; 131(5):1393-9.e5. PubMed ID: 23265858
[TBL] [Abstract][Full Text] [Related]
4. Activated invariant natural killer T cells directly recognize leukemia cells in a CD1d-independent manner.
Aoki T; Takami M; Takatani T; Motoyoshi K; Ishii A; Hara A; Toyoda T; Okada R; Hino M; Koyama-Nasu R; Kiuchi M; Hirahara K; Kimura MY; Nakayama T; Shimojo N; Motohashi S
Cancer Sci; 2020 Jul; 111(7):2223-2233. PubMed ID: 32324315
[TBL] [Abstract][Full Text] [Related]
5. Exploiting the CD1d-iNKT cell axis for potentiation of DC-based cancer vaccines.
Lameris R; Schneiders FL; de Gruijl TD; van der Vliet HJ
Methods Mol Biol; 2014; 1139():155-65. PubMed ID: 24619678
[TBL] [Abstract][Full Text] [Related]
6. Dendritic cell internalization of α-galactosylceramide from CD8 T cells induces potent antitumor CD8 T-cell responses.
Choi DH; Kim KS; Yang SH; Chung DH; Song B; Sprent J; Cho JH; Sung YC
Cancer Res; 2011 Dec; 71(24):7442-51. PubMed ID: 22028323
[TBL] [Abstract][Full Text] [Related]
7. Enhancing the antitumor functions of invariant natural killer T cells using a soluble CD1d-CD19 fusion protein.
Das R; Guan P; Wiener SJ; Patel NP; Gohl TG; Evans E; Zauderer M; Nichols KE
Blood Adv; 2019 Mar; 3(5):813-824. PubMed ID: 30858151
[TBL] [Abstract][Full Text] [Related]
8. Innate Invariant NKT Cell Recognition of HIV-1-Infected Dendritic Cells Is an Early Detection Mechanism Targeted by Viral Immune Evasion.
Paquin-Proulx D; Gibbs A; Bächle SM; Checa A; Introini A; Leeansyah E; Wheelock CE; Nixon DF; Broliden K; Tjernlund A; Moll M; Sandberg JK
J Immunol; 2016 Sep; 197(5):1843-51. PubMed ID: 27481843
[TBL] [Abstract][Full Text] [Related]
9. CD1d highly expressed on DCs reduces lung tumor burden by enhancing antitumor immunity.
Li Y; Zhao C; Liu J; Lu Z; Lu M; Gu J; Liu R
Oncol Rep; 2019 May; 41(5):2679-2688. PubMed ID: 30864713
[TBL] [Abstract][Full Text] [Related]
10. Turned on by danger: activation of CD1d-restricted invariant natural killer T cells.
Lawson V
Immunology; 2012 Sep; 137(1):20-7. PubMed ID: 22734667
[TBL] [Abstract][Full Text] [Related]
11. Identification of distinct human invariant natural killer T-cell response phenotypes to alpha-galactosylceramide.
Croudace JE; Curbishley SM; Mura M; Willcox CR; Illarionov PA; Besra GS; Adams DH; Lammas DA
BMC Immunol; 2008 Dec; 9():71. PubMed ID: 19055753
[TBL] [Abstract][Full Text] [Related]
12. On/off TLR signaling decides proinflammatory or tolerogenic dendritic cell maturation upon CD1d-mediated interaction with invariant NKT cells.
Caielli S; Conforti-Andreoni C; Di Pietro C; Usuelli V; Badami E; Malosio ML; Falcone M
J Immunol; 2010 Dec; 185(12):7317-29. PubMed ID: 21078913
[TBL] [Abstract][Full Text] [Related]
13. Dendritic cells combined with tumor cells and α-galactosylceramide induce a potent, therapeutic and NK-cell dependent antitumor immunity in B cell lymphoma.
Escribà-Garcia L; Alvarez-Fernández C; Tellez-Gabriel M; Sierra J; Briones J
J Transl Med; 2017 May; 15(1):115. PubMed ID: 28549432
[TBL] [Abstract][Full Text] [Related]
14. CD1d expression in glioblastoma is a promising target for NKT cell-based cancer immunotherapy.
Hara A; Koyama-Nasu R; Takami M; Toyoda T; Aoki T; Ihara F; Kobayashi M; Hirono S; Matsutani T; Nakayama T; Iwadate Y; Motohashi S
Cancer Immunol Immunother; 2021 May; 70(5):1239-1254. PubMed ID: 33128583
[TBL] [Abstract][Full Text] [Related]
15. A Potent CD1d-binding Glycolipid for iNKT-Cell-based Therapy Against Human Breast Cancer.
Seki T; Liu J; Brutkiewicz RR; Tsuji M
Anticancer Res; 2019 Feb; 39(2):549-555. PubMed ID: 30711929
[TBL] [Abstract][Full Text] [Related]
16. Murine CD8
Oh S; Lee H; Shin JH; Hong C; Park SH
Immunol Invest; 2018 Jan; 47(1):89-100. PubMed ID: 29099628
[TBL] [Abstract][Full Text] [Related]
17. Invariant natural killer T cells generated from human adult hematopoietic stem-progenitor cells are poly-functional.
Sun W; Wang Y; East JE; Kimball AS; Tkaczuk K; Kesmodel S; Strome SE; Webb TJ
Cytokine; 2015 Mar; 72(1):48-57. PubMed ID: 25569376
[TBL] [Abstract][Full Text] [Related]
18. Function and expression of CD1d and invariant natural killer T-cell receptor in the cotton rat (Sigmodon hispidus).
Fichtner AS; Paletta D; Starick L; Schumann RF; Niewiesk S; Herrmann T
Immunology; 2015 Dec; 146(4):618-29. PubMed ID: 26346465
[TBL] [Abstract][Full Text] [Related]
19. A single amino acid defines cross-species reactivity of tree shrew (Tupaia belangeri) CD1d to human invariant natural killer T (iNKT) cells.
Zhang P; Li D; Stewart-Jones G; Shao X; Zhang Y; Chen Q; Li Y; He YW; Xu XN; Zhang HT
Immunology; 2009 Dec; 128(4):500-10. PubMed ID: 19863613
[TBL] [Abstract][Full Text] [Related]
20. West Nile virus-infected human dendritic cells fail to fully activate invariant natural killer T cells.
Kovats S; Turner S; Simmons A; Powe T; Chakravarty E; Alberola-Ila J
Clin Exp Immunol; 2016 Nov; 186(2):214-226. PubMed ID: 27513522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
